arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

4D Molecular Therapeutics, Inc.

FDMT Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$11.04
▼ -12.6% Today
as of Oct 23, 11:17 ET
Last 30 days -20.28% Sep 14 → Oct 23
$10.58 $12.00 $13.43 $14.85 $16.27 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$12.60
High
$13.12
Low
$11.68
Volume
$1M
Avg Vol
$899,327
Mkt Cap
$765M
P/E (TTM)
—
Beta
—
52w High
$16.93
52w Low
$6.96
Div Yield
—
Shares Out
$55M

Recent Press Releases & News last 60 days · 1 item

Sep 28 · 17:15 Stocktwits
OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs

FDMT earnings at a glance

The options market is pricing a move of about ±14.3% after the report, a range of roughly $9.47 to $12.61 from today's $11.04. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.4% on average; after the most recent report on May 7, 2026 it moved -4.7%. That means options currently expect more movement than FDMT has typically delivered. FDMT beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 91%. The share price of $11.04 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$6.96
$17
41% of range
Avg surprise (last 4)
-4.2%
Avg reaction (last 2)
-0.3%
50% positive
Latest IV / EM
91%
EM ±14.3% · $14 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.04$-0.84$-0.64$-0.44$-0.24 Actual $-0.88Actual $-0.77Actual $-0.24Actual $-0.66Actual $-0.63Actual $-0.79Actual $-0.86Est $-0.84Actual $-0.98Est $-0.88Actual $-1.01Est $-1.02Actual $-1.01Est $-0.97Actual $-1.04 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-73M$-54M$-34M$-15M$4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.04 — — — — financials
Thu May 7, 2026Mar/2026 $-1.01 $-0.97 -4.1% -17.4% -4.7% earnings
Mon Nov 10, 2025Sep/2025 $-1.01 $-1.02 +1.0% — — earnings
Mon Aug 11, 2025Jun/2025 $-0.98 $-0.88 -11.4% — — earnings
Thu May 8, 2025Mar/2025 $-0.86 $-0.84 -2.4% — +4.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.79 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.63 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.66 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.24 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.77 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.88 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$4M$3M—$90,000$15,000$14,000—$3,000
Cost of revenue————————
Gross profit————————
Operating income$-77M$-74M—$-61M$-59M$-54M—$-51M
Net income$-73M$-69M—$-57M$-55M$-48M—$-44M
EPS (diluted)$-1.04$-1.01—$-1.01$-0.98$-0.86—$-0.79

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$70M$72M$60M$49M$77M$134M$149M$188M
Inventory————————
Total current assets$383M$405M$413M$312M$303M$333M$435M$511M
Total assets$493M$513M$567M$424M$474M$516M$560M$604M
Long-term debt$20M—$0—————
Total liabilities$85M$61M$61M$55M$53M$46M$50M$51M
Total equity$408M$452M$506M$369M$421M$470M$511M$553M

Implied volatility — last 90 days

54%185%317%448%580% Jun 08 — IV 136% · EM ±17.9%Jun 15 — IV 247% · EM ±17.9%Jun 19 — IV 167% · EM ±37.0%Jun 22 — IV 182% · EM ±37.9%Jun 23 — IV 62% · EM ±12.7%Jun 24 — IV 223% · EM ±44.8%Jun 25 — IV 222% · EM ±43.4%Jun 29 — IV 59% · EM ±10.5%Jun 30 — IV 105% · EM ±18.0%Jul 01 — IV 125% · EM ±20.9%Jul 02 — IV 76% · EM ±12.3%Jul 03 — IV 79% · EM ±12.3%Jul 20 — IV 228% · EM ±53.8%Jul 21 — IV 142% · EM ±33.0%Jul 22 — IV 100% · EM ±22.8%Jul 28 — IV 79% · EM ±16.2%Jul 29 — IV 75% · EM ±15.1%Jul 30 — IV 80% · EM ±15.6%Jul 31 — IV 264% · EM ±50.6%Aug 03 — IV 280% · EM ±49.6%Aug 04 — IV 283% · EM ±48.7%Aug 05 — IV 300% · EM ±50.1%Aug 06 — IV 293% · EM ±47.4%Aug 13 — IV 170% · EM ±20.1%Aug 17 — IV 293% · EM ±24.5%Aug 20 — IV 580% · EM ±24.2%Aug 25 — IV 80% · EM ±16.4%Aug 26 — IV 55% · EM ±10.9%Aug 27 — IV 119% · EM ±23.3%Aug 28 — IV 80% · EM ±15.3%Aug 31 — IV 63% · EM ±11.2%Sep 01 — IV 137% · EM ±23.5%Sep 02 — IV 86% · EM ±14.4%Sep 03 — IV 69% · EM ±11.2%Sep 04 — IV 75% · EM ±11.7%Sep 07 — IV 84% · EM ±11.7%Sep 08 — IV 88% · EM ±11.6%Sep 09 — IV 156% · EM ±19.6%Sep 15 — IV 396% · EM ±28.6%Sep 21 — IV 71% · EM ±14.8%Sep 22 — IV 86% · EM ±17.6%Sep 23 — IV 77% · EM ±15.3%Sep 24 — IV 66% · EM ±12.9%Sep 25 — IV 184% · EM ±35.2%Sep 28 — IV 118% · EM ±20.9%Sep 29 — IV 200% · EM ±34.5%Oct 02 — IV 91% · EM ±14.3%

Sector peers

CADL
Candel Therapeutics, Inc.
$777M $8.05-3.8%
DNA
Ginkgo Bioworks Holdings, Inc.
$738M $9.73-2.8%
SLDB
Solid Biosciences Inc.
$734M $5.87-8.4%
SANA
Sana Biotechnology, Inc.
$814M $2.29-2.8%
PRME
Prime Medicine, Inc.
$707M $3.48-8.5%
GLUE
Monte Rosa Therapeutics, Inc.
$868M $10.78-3.9%

FDMT earnings FAQ

What is FDMT's expected move for earnings?

Options currently price a move of about ±14.3%, or $1.57 per share either way from $11.04.

How does FDMT stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.4%, up 1 times and down 1 times.

What is FDMT's implied volatility?

FDMT's at-the-money implied volatility is about 91% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in